What is Edesa Biotech, Inc. Common Shares's Market Cap?

Edesa Biotech, Inc. Common Shares's Market Cap is $45.6M, based on as-reported figures from SEC (XBRL) filings.

What is Edesa Biotech, Inc. Common Shares's Enterprise Value?

Edesa Biotech, Inc. Common Shares's Enterprise Value is $35.3M, based on as-reported figures from SEC (XBRL) filings.

What is Edesa Biotech, Inc. Common Shares's EV / EBITDA?

Edesa Biotech, Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Edesa Biotech, Inc. Common Shares's Net Income (TTM)?

Edesa Biotech, Inc. Common Shares's Net Income (TTM) is -$14.1M, based on as-reported figures from SEC (XBRL) filings.

What is Edesa Biotech, Inc. Common Shares's EBITDA?

Edesa Biotech, Inc. Common Shares's EBITDA is -$14.5M, based on as-reported figures from SEC (XBRL) filings.

What is Edesa Biotech, Inc. Common Shares's Diluted EPS (TTM)?

Edesa Biotech, Inc. Common Shares's Diluted EPS (TTM) is -1.46, based on as-reported figures from SEC (XBRL) filings.

What is Edesa Biotech, Inc. Common Shares's Net Debt?

Edesa Biotech, Inc. Common Shares's Net Debt is -$10.3M, based on as-reported figures from SEC (XBRL) filings.

Edesa Biotech, Inc. Common Shares (EDSA) Financial Statements

Edesa Biotech, Inc. Common Shares

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001SPM284

XNAS · usd

4.73▲ 0.00 (0.00%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)—

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close4.73

Day's Range4.69 – 4.91

52-Week Range0.72 – 20.32

Volume32.0K

Avg Volume76.0K

Share Statistics

Shares Outstanding

Employees17

ExchangeXNAS

Listed2010-06-09

Share count as of August 13, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Edesa Biotech, Inc. Common Shares (EDSA)

What is Edesa Biotech, Inc. Common Shares's Market Cap?: Edesa Biotech, Inc. Common Shares's Market Cap is $45.6M, based on as-reported figures from SEC (XBRL) filings.
What is Edesa Biotech, Inc. Common Shares's Enterprise Value?: Edesa Biotech, Inc. Common Shares's Enterprise Value is $35.3M, based on as-reported figures from SEC (XBRL) filings.
What is Edesa Biotech, Inc. Common Shares's EV / EBITDA?: Edesa Biotech, Inc. Common Shares's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Edesa Biotech, Inc. Common Shares's Net Income (TTM)?: Edesa Biotech, Inc. Common Shares's Net Income (TTM) is -$14.1M, based on as-reported figures from SEC (XBRL) filings.
What is Edesa Biotech, Inc. Common Shares's EBITDA?: Edesa Biotech, Inc. Common Shares's EBITDA is -$14.5M, based on as-reported figures from SEC (XBRL) filings.
What is Edesa Biotech, Inc. Common Shares's Diluted EPS (TTM)?: Edesa Biotech, Inc. Common Shares's Diluted EPS (TTM) is -1.46, based on as-reported figures from SEC (XBRL) filings.
What is Edesa Biotech, Inc. Common Shares's Net Debt?: Edesa Biotech, Inc. Common Shares's Net Debt is -$10.3M, based on as-reported figures from SEC (XBRL) filings.